TY  - JOUR
A1  - Mathur, Anthony
A1  - Fernández-Avilés, Francisco
A1  - Dimmeler, Stefanie
A1  - Hauskeller, Christine
A1  - Janssens, Stefan
A1  - Menasche, Philippe
A1  - Wojakowski, Wojtek
A1  - Martin, John F.
A1  - Zeiher, Andreas M.
T1  - The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure : update 2016
T2  - European heart journal
N2  - In 2006, the Task Force of the European Society of Cardiology published its consensus document on the use of autologous cell therapy for repair of the heart. Since then, there have been numerous clinical trials and analyses performed to establish the role of autologous cell therapy in the treatment of both acute and chronic cardiac disease. The majority of these studies have been Phase II clinical trials. Phase III clinical trials of autologous cell therapy have been launched (e.g. BAMI), which marks the successful progression of clinical investigation of autologous cell therapy in heart disease. The Task Force has reviewed its 2006 recommendations and the developments in this area of research and proposes updated recommendations for the future of autologous cell therapy in the heart. This article does not duplicate the many reviews on stem cells and the heart but gives considered recommendations based on the experience from the last 10 years.
Y1  - 2017
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/44710
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-447102
SN  - 1522-9645
SN  - 0195-668X
N1  - © The Author 2017. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
VL  - 38
IS  - 39
SP  - 2930
EP  - 2935
PB  - Oxford University Press
CY  - Oxford
ER  -